DSGN — Design Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Design Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	36.1	384	330	282	245
Net Total Receivables	—	—	—	1.43	1.26
Prepaid Expenses
Total Other Current Assets
Total Current Assets	36.2	385	335	285	248
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.071	5.12	5.56	4.63	3.63
Other Long Term Assets
Total Assets	36.5	391	341	290	252
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	2.33	5.28	10.8	9.62	8.46
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.48	8.43	13.8	12	10
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	34	382	327	278	242
Total Liabilities & Shareholders' Equity	36.5	391	341	290	252
Total Common Shares Outstanding